In the U.S., 1 in 5 prescriptions is written for an off-label use.1 While sometimes this allows medications to be overused or misused, it also protects doctors’ ability to freely treat patients, and patients’ ability to use all available treatments after making an informed decision. That 20% of medications are used off-label also indicates “a… Read More »
In the video above, Glenn Beck interviews investigative journalist Whitney Webb about her book, “One Nation Under Blackmail: The Sordid Union Between Intelligence and Crime That Gave Rise to Jeffrey Epstein,” Parts 1 and 2. These books provide the necessary framework to understand not just Jeffrey Epstein’s geopolitical role and function, but also, more broadly,… Read More »
In the video above Alexis Baden-Mayer, political director for the Organic Consumers Association (OCA), interviews Gretchen DuBeau, the executive and legal director for the Alliance for Natural Health, who in addition to being a lawyer also has a master’s degree in applied healing arts, talk about Big Pharma’s efforts to eliminate one of its greatest… Read More »
Takeda is investing more in cell and gene therapy through new deals with Poseida Therapeutics and Immusoft targeting liver and neurometabolic disorders, respectively. BeiGene’s Abraxane China licensing deal with Bristol Myers Squibb’s Celgene is falling apart amid manufacturing problems and a legal battle. And more. 1. Billions club: Takeda taps Poseida for 2nd $ 1B-plus gene… Read More »
The Biden administration’s call to waive patent rights for coronavirus vaccines sparked vociferous opposition from drugmakers and pharma industry groups, which quickly claimed the move will discourage future drug research and do little to increase supply. Activists, who have pressured the administration for months on the issue, argue a waiver is needed to begin removing… Read More »
Alexa, show me the future of drug advertising? Bayer Consumer Health’s first-ever Alexa interactive ad allows consumers to buy an OTC product by talking to the Amazon device—and may foreshadow broader trends in the industry. The U.K. ad for Bayer’s Berocca Boost, a vitamin and caffeine tablet, is running as a trial during programming streamed by Global,… Read More »